A Pfizer executive told the European Union parliament this week that the company’s COVID-19 vaccine was not tested for the purpose of stopping transmission of the virus before it hit the market.
Janine Small, Pfizer’s president of international developed markets, testified before the EU Parliament’s Special Committee on COVID-19 Pandemic about the company’s conduct during the ongoing coronavirus outbreak. During the hearing, Dutch MEP Robert Roos asked Small if COVID-19 vaccines had been tested for stopping transmission before they became available, Small answered “no.”
“Regarding the question around, did we know about stopping immunization before it entered the market, no,” Small said. “We had to really move at the speed of science to really understand what is taking place in the market.”
